Phenotyping of Airway Diseases – ‘One Size Fits the Most – But Some Are Different’
S.K. Jinda
Citation Information :
Jinda S. Phenotyping of Airway Diseases – ‘One Size Fits the Most – But Some Are Different’. Indian J Chest Dis Allied Sci 2019; 61 (1):5-6.
Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R. Multidimentional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy 2005;35:1254–62.
Carolan BJ, Sutherland ER. Clinical phenotypes of chronic obstructive pulmonary disease and asthma: recent advances. J Allergy Clin Immunol 2013;131:627–34.
Lotvall J, Akdis CA, Bacharier LB, Biermer L, Casale TB, Custovic A, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011;127:355–60.
Borish L, Culp JA. Asthma: a syndrome composed of heterogeneous diseases. Ann Allergy Asthma Immunol 2008;101:1–9.
Bradding P, Green RH. Subclinical phenotypes of asthma. Curr Opin Allergy Clin Immunol 2010;10:54–9.
Liu AH. Treatment of asthma with anti-immunoglobulin E monoclonal antibody. Allergy Asthma Proc 2006;27 (2 Suppl. 1): S24–8.
Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, et al. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 2005;60:302–8.
Nair P, Dasgupta A, Brightling CE, Chung KF. How to diagnose and phenotype asthma? Clin Chest Med 2012;33:445–57.
Holgate ST. Novel targets of therapy in asthma. Curr Opin Pulm Med 2009;15:63–71.
Kon OM, Sihra BS, Compton CH, Leonard TB, Kay AB, Barnes NC. Randomised, dose ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe a sthma. Lancet 1998;352(9134):1109–13.
Le Rouzic O, Roche N, Cortot AB, Tillie-Leblond I, Masure F, Perez T, et al. Defining the “Frequent Exacerbator” phenotype in COPD: a hypothesis-free approach. Chest 2018:153:1106–15.
Calle Rubio M, Casamor R, Miravitlles M. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study. Int J Chron Obstruct Pulmon Dis 2017;12:2373–83.
Cheng Y, Tu X, Pan L, Lu S, Xing M, Li L, et al. Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations. Int J Chron Obstruct Pulmon Dis 2017;12:2069–74.
Jindal SK. Chronic obstructive pulmonary disease in nonsmokers - Is it a different phenotype? Indian J Med Res 2018;147:337–9.
Lee SH, Hwang ED, Lim JE, Moon S, Kang YA, Jung JY, et al. The risk factors and characteristics of COPD among nonsmokers in Korea: an analysis of KNHANES IV and V. Lung 2016;194: 353–61.
Moran-Mendoza O, Perez-Padilla JR, Salazar-Flores M, Vazquez- Alfaro F. Wood smoke associated lung disease: a clinical, functional, radiological and pathological description. Int J Tuberc Lung Dis 2008;12:1092–8.
